Development of nanocomplex mimic‐hsa‐miR‐143‐3p loaded exosome (exo‐miR) to inhibit viability, migration and proliferation of triple‐negative breast cancer

Breast cancer represents the highest number of cancer cases in Indonesia, with triple‐negative breast cancer (TNBC) being a common subtype (10–15%). MicroRNAs play a role in cancer epigenetics and contributing as core factors to the disease. The expression of miR‐143‐3p have been found to be lower i...

Full description

Saved in:
Bibliographic Details
Main Authors: Fita Nilasari, Sofia Mubarika Haryana, Dwi Aris Agung Nugrahaningsih, Pamungkas Bagus Satriyo
Format: Article
Language:English
Published: Universitas Gadjah Mada, Yogyakarta 2024-12-01
Series:Indonesian Journal of Biotechnology
Subjects:
Online Access:https://jurnal.ugm.ac.id/ijbiotech/article/view/92817
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849732603327807488
author Fita Nilasari
Sofia Mubarika Haryana
Dwi Aris Agung Nugrahaningsih
Pamungkas Bagus Satriyo
author_facet Fita Nilasari
Sofia Mubarika Haryana
Dwi Aris Agung Nugrahaningsih
Pamungkas Bagus Satriyo
author_sort Fita Nilasari
collection DOAJ
description Breast cancer represents the highest number of cancer cases in Indonesia, with triple‐negative breast cancer (TNBC) being a common subtype (10–15%). MicroRNAs play a role in cancer epigenetics and contributing as core factors to the disease. The expression of miR‐143‐3p have been found to be lower in breast cancer samples from Yogyakarta and Central Java. It is known that miR‐143‐3p functions as a tumor suppressor in breast cancer, and its overexpression corresponds with an increased survival rate. The structure of miRNA is quickly degraded, an enhanced delivery system for miRNA is required. Exosomes are indeed emerging as natural delivery agent. A new approach represents that exosomes will be transfected with mimic‐hsa‐miR‐143‐3p yield an exo‐miR. The research aimed to examine how exo‐miR affects viability, migration, and proliferation using 4T1 cell line. The Exo‐Fect‐based method was used to transfect mimic‐hsa‐miR‐143‐3p into exosomes. The MTT assay, wound healing assay, and colony formation assay were used as functional assay. The MTT assay revealed that 7.5 µL/ 250,000 particles exo‐miR obtained a lower percentage of cell viability (58%) than the control (99.7%). The wound healing assay showed that transfection of 37.5 µL/ 1,250,000 particles exo‐miR was able to suppress migration by the percentage of wound closure (67%) compared to the control (100%). Exo‐miR also had a significant (p < 0.001) effect on colony‐forming abilities, as shown by fewer colonies (32) compared to the control (132). This findings demonstrated that exo‐miR represents a promising targeted approach in cancer therapy.
format Article
id doaj-art-219aaa8d0ffb43b28deffe0ec4bb12b6
institution DOAJ
issn 0853-8654
2089-2241
language English
publishDate 2024-12-01
publisher Universitas Gadjah Mada, Yogyakarta
record_format Article
series Indonesian Journal of Biotechnology
spelling doaj-art-219aaa8d0ffb43b28deffe0ec4bb12b62025-08-20T03:08:18ZengUniversitas Gadjah Mada, YogyakartaIndonesian Journal of Biotechnology0853-86542089-22412024-12-0129419019710.22146/ijbiotech.9281737002Development of nanocomplex mimic‐hsa‐miR‐143‐3p loaded exosome (exo‐miR) to inhibit viability, migration and proliferation of triple‐negative breast cancerFita Nilasari0Sofia Mubarika Haryana1Dwi Aris Agung Nugrahaningsih2Pamungkas Bagus Satriyo3Study Program of Master in Biotechnology, Graduate School, Universitas Gadjah Mada, Yogyakarta 55281, IndonesiaDepartment of Histology and Cellular Biology, Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta 55281, IndonesiaDepartment of Pharmacology and Therapy, Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta 55281, IndonesiaDepartment of Pharmacology and Therapy, Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta 55281, IndonesiaBreast cancer represents the highest number of cancer cases in Indonesia, with triple‐negative breast cancer (TNBC) being a common subtype (10–15%). MicroRNAs play a role in cancer epigenetics and contributing as core factors to the disease. The expression of miR‐143‐3p have been found to be lower in breast cancer samples from Yogyakarta and Central Java. It is known that miR‐143‐3p functions as a tumor suppressor in breast cancer, and its overexpression corresponds with an increased survival rate. The structure of miRNA is quickly degraded, an enhanced delivery system for miRNA is required. Exosomes are indeed emerging as natural delivery agent. A new approach represents that exosomes will be transfected with mimic‐hsa‐miR‐143‐3p yield an exo‐miR. The research aimed to examine how exo‐miR affects viability, migration, and proliferation using 4T1 cell line. The Exo‐Fect‐based method was used to transfect mimic‐hsa‐miR‐143‐3p into exosomes. The MTT assay, wound healing assay, and colony formation assay were used as functional assay. The MTT assay revealed that 7.5 µL/ 250,000 particles exo‐miR obtained a lower percentage of cell viability (58%) than the control (99.7%). The wound healing assay showed that transfection of 37.5 µL/ 1,250,000 particles exo‐miR was able to suppress migration by the percentage of wound closure (67%) compared to the control (100%). Exo‐miR also had a significant (p < 0.001) effect on colony‐forming abilities, as shown by fewer colonies (32) compared to the control (132). This findings demonstrated that exo‐miR represents a promising targeted approach in cancer therapy.https://jurnal.ugm.ac.id/ijbiotech/article/view/92817exosomemigrationmimic‐hsa‐mir‐143‐3pproliferationtnbcviability
spellingShingle Fita Nilasari
Sofia Mubarika Haryana
Dwi Aris Agung Nugrahaningsih
Pamungkas Bagus Satriyo
Development of nanocomplex mimic‐hsa‐miR‐143‐3p loaded exosome (exo‐miR) to inhibit viability, migration and proliferation of triple‐negative breast cancer
Indonesian Journal of Biotechnology
exosome
migration
mimic‐hsa‐mir‐143‐3p
proliferation
tnbc
viability
title Development of nanocomplex mimic‐hsa‐miR‐143‐3p loaded exosome (exo‐miR) to inhibit viability, migration and proliferation of triple‐negative breast cancer
title_full Development of nanocomplex mimic‐hsa‐miR‐143‐3p loaded exosome (exo‐miR) to inhibit viability, migration and proliferation of triple‐negative breast cancer
title_fullStr Development of nanocomplex mimic‐hsa‐miR‐143‐3p loaded exosome (exo‐miR) to inhibit viability, migration and proliferation of triple‐negative breast cancer
title_full_unstemmed Development of nanocomplex mimic‐hsa‐miR‐143‐3p loaded exosome (exo‐miR) to inhibit viability, migration and proliferation of triple‐negative breast cancer
title_short Development of nanocomplex mimic‐hsa‐miR‐143‐3p loaded exosome (exo‐miR) to inhibit viability, migration and proliferation of triple‐negative breast cancer
title_sort development of nanocomplex mimic hsa mir 143 3p loaded exosome exo mir to inhibit viability migration and proliferation of triple negative breast cancer
topic exosome
migration
mimic‐hsa‐mir‐143‐3p
proliferation
tnbc
viability
url https://jurnal.ugm.ac.id/ijbiotech/article/view/92817
work_keys_str_mv AT fitanilasari developmentofnanocomplexmimichsamir1433ploadedexosomeexomirtoinhibitviabilitymigrationandproliferationoftriplenegativebreastcancer
AT sofiamubarikaharyana developmentofnanocomplexmimichsamir1433ploadedexosomeexomirtoinhibitviabilitymigrationandproliferationoftriplenegativebreastcancer
AT dwiarisagungnugrahaningsih developmentofnanocomplexmimichsamir1433ploadedexosomeexomirtoinhibitviabilitymigrationandproliferationoftriplenegativebreastcancer
AT pamungkasbagussatriyo developmentofnanocomplexmimichsamir1433ploadedexosomeexomirtoinhibitviabilitymigrationandproliferationoftriplenegativebreastcancer